Muresan, A
Conditions Locations Treatment Type Trial Phase Trial Status Paid Participation Trial Details Key Eligibility Criteria 20 Participants Needed Trial Details Key Eligibility Criteria 134 Participants Needed Trial Details Key Eligibility Criteria 60 Participants Needed Trial Details Key Eligibility Criteria 33 Participants Needed Trial Details Key Eligibility Criteria 140 Participants Needed Trial Details Key Eligibility Criteria 100 Participants Needed Trial Details Key Eligibility Criteria 1000 Participants Needed Trial Details Key Eligibility Criteria 1020 Participants Needed Trial Details Key Eligibility Criteria 60 Participants Needed Trial Details Key Eligibility Criteria 80 Participants Needed Trial Details Key Eligibility Criteria 154 Participants Needed Trial Details Key Eligibility Criteria 36 Participants Needed Trial Details Key Eligibility Criteria 60 Participants Needed Trial Details Key Eligibility Criteria 100 Participants Needed Trial Details Key Eligibility Criteria 50 Participants Needed Trial Details Key Eligibility Criteria 50 Participants Needed Trial Details Key Eligibility Criteria 80 Participants Needed Trial Details Key Eligibility Criteria 23 Participants Needed Trial Details Key Eligibility Criteria 140 Participants Needed Trial Details Key Eligibility Criteria 28 Participants Needed "I've tried several different SSRIs over the past 23 years with no luck
The disease affects about 5 million Americans, mostly over age 40
Seizure 91:278286 Wedemeyer F, Kaminski JA, Zillich L, Hall ASM, Friedel E, Witt SH (2020) Prospects of genetics and epigenetics of alcohol use disorder
(2) Loren Pickart, Jessica Michelle Vasquez-Soltero, and Anna Margolina (2015) GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration Biomed Research International, 2015, Volume 2015, Page 648108
